ASHG 2016
Recent articles
Many people harbor large mutations linked to autism
DNA deletions and duplications tied to autism crop up in people without the condition, too.
Many people harbor large mutations linked to autism
DNA deletions and duplications tied to autism crop up in people without the condition, too.
Drug duo may reverse effects of Rett mutations in cells
A pair of existing drugs normalizes the appearance and activity of neurons derived from the skin of individuals with Rett syndrome.
Drug duo may reverse effects of Rett mutations in cells
A pair of existing drugs normalizes the appearance and activity of neurons derived from the skin of individuals with Rett syndrome.
‘Synonymous’ mosaic mutations may up autism risk
A type of mutation long thought to be harmless has turned out to play an unexpected role in autism.
‘Synonymous’ mosaic mutations may up autism risk
A type of mutation long thought to be harmless has turned out to play an unexpected role in autism.
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.